Search results
Results from the WOW.Com Content Network
The journal provides commentary and analysis to elucidate best clinical practice in hematology and to translate advances in research – in areas such as immunology, stem cell research, and cell and gene therapy – into the clinical context. Each review includes an ‘expert commentary’ and a 'five-year view' section, in which authors are ...
Blood is a peer-reviewed medical journal published by the American Society of Hematology.It was established by William Dameshek in 1946. The journal changed from semimonthly (24 times annually) to weekly publication at the start of 2009.
Experimental Hematology is a peer-reviewed medical journal of hematology, which publishes original research articles and reviews, as well as the abstracts of the annual proceedings of the Society for Hematology and Stem Cells (formerly known as the International Society for Experimental Hematology).
American Journal of Hematology is an academic journal devoted to the coverage of blood diseases. It has been published since 1976. The editor-in-chief is Carlo Brugnara (Harvard Medical School). [1] According to the Journal Citation Reports, the journal has a 2022 impact factor of 12.8, ranking it 7th out of 76 journals in the category ...
D56.1: 3087: Beta-thalassemia (β-thalassemia) is an autosomal dominant blood condition that results in the reduction of hemoglobin production. The cause for the disorder is related to a genetic mutation of the HBB gene. This gene is responsible for providing the instructions to produce beta-globin; one of the major components of hemoglobin.
Hematology (spelled haematology in British English) is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. [ 1 ] [ 2 ] It involves treating diseases that affect the production of blood and its components, such as blood cells , hemoglobin , blood proteins , bone marrow ...
Kirsten Bibbins-Domingo of the University of California San Francisco became the journal editor-in-chief on July 1, 2022, succeeding Howard Bauchner of Boston University. [ 2 ] According to Journal Citation Reports , the journal's 2024 impact factor is 63.1, ranking it 4th out of 168 journals in the category "Medicine, General & Internal".
While prognosis is highly variable and dependent on various factors including these mutations, the average 5-year relative survival is 86.1%. [85] Telomere length has been suggested to be a valuable prognostic indicator of survival. [86] In addition, a person's sex has been found to have an impact on CLL prognosis and treatment efficacy.